<p>药明合联 (02268.HK) +1.050 (+1.966%) 空头头寸 $61.54M; 比率 21.540% 宣布公司决定利用内部资金最多达 1 亿美元，委托专业受托人根据公司不时的股份计划在公开市场以现行市场价格购买股份。</p>
<p>公司认为，当前股份的交易价格并未反映其内在价值或公司的实际商业前景，这为公司进行拟议的股份回购提供了良好机会。</p>
<p>药明合联今早开盘上涨 2.15%，报 HKD54.55，盘前交易 19,600 股，涉及 HKD1.07 百万。</p>
<p>（香港股票报价延迟至少 15 分钟。空头数据截至 2026-05-18 16:25。）</p>

药明合联

<p>药明合联开盘上涨 2.15%，报 54.55 港元，成交 19,600 股。该公司宣布计划回购最多 1 亿美元的股份，认为当前的交易价格并未反映其内在价值或商业前景</p>

<p>WUXI XDC (02268.HK) +1.050 (+1.966%)  Short selling $61.54M; Ratio 21.540%  announced that it resolved to utilize internal funds of up to US$100 million for the professional trustee appointed by the Company in respect of the share schemes of the Company from time to time to purchase the Shares in the open market at the prevailing market price.</p>
<div class="lb-trans"><p>药明合联 (02268.HK) +1.050 (+1.966%) 空头头寸 $61.54M; 比率 21.540% 宣布公司决定利用内部资金最多达 1 亿美元，委托专业受托人根据公司不时的股份计划在公开市场以现行市场价格购买股份。</p>
</div><p>The Company believed that the current trading price of the Shares does not reflect their intrinsic value or the actual business prospects of the Company, which represents a good opportunity for the Company to conduct the Proposed Share Purchase.</p>
<div class="lb-trans"><p>公司认为，当前股份的交易价格并未反映其内在价值或公司的实际商业前景，这为公司进行拟议的股份回购提供了良好机会。</p>
</div><p>WUXI XDC opened 2.15% higher this morning at HKD54.55, with 19,600 shares traded in the pre-market session, involving HKD1.07 million.</p>
<div class="lb-trans"><p>药明合联今早开盘上涨 2.15%，报 HKD54.55，盘前交易 19,600 股，涉及 HKD1.07 百万。</p>
</div><p>(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-18 16:25.)</p>
<div class="lb-trans"><p>（香港股票报价延迟至少 15 分钟。空头数据截至 2026-05-18 16:25。）</p>
</div>

药明合联开盘上涨 2.15%，计划回购股份金额最高达 1 亿美元